Reduction of Renal Uptake of Monoclonal Antibody Fragments by Amino Acid Infusion

Journal of Nuclear Medicine

Volumn 37, Issue 5, 1996, Pages 829-833

  Behr, Thomas M ^b   Becker, Wolfgang S ^b   Sharkey, Robert M ^b   Juweid, Malik E ^b   Dunn, Robert M ^b   Bair, Hans J ^b   Wolf, Friedrich G ^b   Goldenberg, David M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b NONE

Author keywords

Cationic amino acids; Fab' fragments; Monoclonal antibodies; Renal uptake reduction

Indexed keywords

AMINO ACID; CARCINOEMBRYONIC ANTIGEN; DIAGNOSTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; SODIUM CHLORIDE; TECHNETIUM;

AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; METABOLISM; MIDDLE AGED; RADIOIMMUNOASSAY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH TUMOR;

AGED; AMINO ACIDS; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; MIDDLE AGED; RADIOIMMUNODETECTION; SODIUM CHLORIDE; STOMACH NEOPLASMS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030140103     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Behr T, Sharkey RM, Juweid M, Aninipot R, Griffiths G, Goldenberg DM. Reduktion des Nierenuptakes Fab'-fragmentierter monoklonaler Antikörper - tierexperimentelle Grundlagen und vorläufige klinische Ergbenisse [Abstract]. Nuklearmedizin 1995;34: A96.
2. Behr TM, Sharkey RM, Juweid ME, Aninipot R, Goldenberg DM. Reduction of the kidney uptake of Fab' fragments of monoclonal antibodies: animal experimental and initial clinical results [Abstract], Proc Am Assoc Cancer Res 1995;86:617.
3. Behr TM, Sharkey RM, Juweid ME, Aninipot R, Griffiths GL. Goldenberg DM. Reduction of kidney uptake of radiolabeled monoclonal antibody (MAb) fragments: preclinical and initial clinical results [Abstract]. J Nucl Med 1995;36:19P.
4. Behr TM, Sharkey RM, Juweid ME, et al. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res 1995;55:3825-3834.
5. Baum RP, Niesen A, Hertel A, et al. Initial clinical results with technetium-99mlabeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas. Cancer 1994;73:896-899.
6. 99mTc-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer. J Nucl Med 1995;36:430-441.
7. Krenning EP, Bakker WH, Kooij PP, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 1992;33:652-658.
8. 99mTc: the role of metabolism and kinetics. Cancer Res 1995;(suppl)55: 5777S-5785S.
9. Morgenson CE, Sailing K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab 1977;37:477-486.
10. Hammond PJ, Wade AF, Gwilliam ME, et al. Amino acid infusion blocks renal tubular uptake of indium-labeled somatostatin analogue. Br J Cancer 1993;67:1437-1439.
11. Pimm MV, Gribben SJ. Prevention of renal tubule re-absorption of radiometal (indium-111) labeled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Ear J Nucl Med 1994;21:663-665.
12. 99mTc-labeling kit for antibody imaging. Cancer Res 1990;50:7945-7985.
13. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945;l:80-83.
14. 99mTcradiolabeled to an Fab' antibody via stannous ion and mercaptoethanol reduction. Nucl Med Commun 1992;13:503-512.
15. Murthy S, Sharkey RM, Goldenberg DM, et al. Lymphoma imaging with a new technetium-99m-labeled antibody, LL2. Eur J Nucl Med 1992;19:394-401.
16. Kramer EL, Noz ME, Liebes L, Murthy S, Tiu S, Goldenberg DM. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcmoembryonic antigen IMMU-4 Fab' fragment preliminary results. Cancer 1994;73:890-895.
17. Tarburton JP, Halpern SE, Hagan PL, et al. Effect of acetylation on monoclonal antibody ZCE-025 Fab': distribution in normal and tumor-bearing mice. J Biol Response Mod 1990;9:221-230.
18. Silbernagl S. The renal handling of amino acids and oligopeptides. Physiol Rev 1988;68:912-986.
19. Zager RA. Amino acid hyperalimentation in acute renal failure: a potential therapeutic paradox. Kidney Int 1987;(suppl 22)32:S72-S75.
20. Abel RM, Beck CH, Abbott WM, Ryan JA, Barnen GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med 1973;288:695-699.
21. Zager RA, Johannes G, Turtle SE, Sharma HM. Acute amino acid nephrotoxicity. J Lab Clin Med 1983;101:130-140.
22. Castellino P, Hunt W, DeFronzo RA. Regulation of renal hemodynamics by plasma amino acid and hormone concentrations. Kidney Int 1987;(suppl 22)32:S15-S20.
23. Dancis J, Hutzier J, Ampoia MG, et al. The prognosis of hyperlysinemia: an interim report. Am J Genet 1983;35:438-442.